BP directly binds to PLK1, aggregating it, decreasing its cytosolic mobility, and restricting its centrosome activation. This mechanism gives BP nanomaterials great anticancer potential in tumor xenografted mice. This evidence concerns the gene PLK1 and neoplasm.